Design and rationale for REVERXaL: A real-world study of patients with factor Xa inhibitor–associated major bleeds
Design and rationale for REVERXaL: A real-world study of patients…
Ler MaisDesign and rationale for REVERXaL: A real-world study of patients…
Ler MaisVenous thromboembolism risk assessment scale for prediction of venous thromboembolism…
Ler MaisAcute cardiovascular complications of disseminated intravascular coagulation in acute myeloid…
Ler MaisType 1 VWD classification revisited: novel insights from combined analysis…
Ler MaisBeing John Plasma Volumovich, pecularities of plasma volume estimation in…
Ler MaisRisk of recurrent venous thromboembolism and bleeding in patients with…
Ler MaisPrevalence and outcome of acute pulmonary embolism in hospitalized patients…
Ler MaisAnticoagulation stewardship: Improving adherence to clinical guidelines and reducing overuse…
Ler MaisPulmonary vein thrombosis: Clinical presentation and outcomes Daniel Sykora a),…
Ler MaisRisk assessment models for PICC-related venous thrombosis in adult patients…
Ler Mais